We are not blocked by gatekeepers as much as we are by habits of waiting. Learned helplessness keeps us stuck long after permission is no longer required.
FDA moves to strike suicide risk warnings from Saxenda, Wegovy, and Zepbound labels after analysis finds no increased risk.
Qualitative responses from 22 people living with MS informed the development of three themes: “self-efficacy for disease management,” “personal control,” and “illness coherence.” Conclusions: Findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback